NASDAQ NMS - GLOBAL MARKET · CNTN
-0.52% · -$0.0100 · Vol 650.7K
After hours · updated 16:21:33 ET
Canton Strategic Holdings Inc

Canton Strategic Holdings Inc

Biotechnology
$1.90
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
CNTN
Canton Strategic Holdings Inc
Stale score · Tue Aug 4 · completed session · 22h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Stale score · Tue Aug 4 · completed session · 22h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CNTN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CNTN catalysts
About Canton Strategic Holdings Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2022
Employees
12
Country
US

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.95
Day high
$1.97
Day low
$1.87
Previous close
$1.91
52W high
$5.14
-63.04% from high
52W low
$1.85
2% of range
Market cap
$147.3M
EPS
$-0.9200
Beta
1.13
Shares out
77.1M
Volume
650.7K
0.66× rel vol
Avg volume
984.4K
VWAP
$1.90
Price history computed in-house
1W
-1.55%
1M
-25.93%
3M
-36.24%
SMA 50 $2.57 · below
SMA 200 Not reported · Not reported
52W position 2%

CNTN overview

Veridion Score
45
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CNTN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CNTN Form 4 filings
Public disclosures

Congress activity in CNTN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CNTN in the cached public ledger.

Federal contracts

CNTN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CNTN in this window.
Lobbying spend

CNTN lobbying filings, year to date.

Registered lobbying filings matched to Canton Strategic Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CNTN in this window.
Loading news for CNTN
Analyst ratings
Sovereign unlock shows live analyst consensus for CNTN.
Options
Sovereign unlock shows live options positioning for CNTN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.